BAJAJ FINSERV DIRECT LIMITED
Open Your FREE Demat Account Now!

Zydus Lifesciences Ltd. Share Price

NSE
BSE

NSE : ZYDUSLIFE

BSE : 532321

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Day's Range

Low

₹936.25

High

₹945.45

Price Summary

Previous Close ₹940.30
Day's Range ₹936.25 - ₹945.45
Open ₹945.00
52 Week Range ₹835.50 - ₹1,059.05
Volume 4,88,635
Market Cap ₹0.09

Stocks Summary

Trade Value ( ₹ in Lacs) 4,597.11
Market Cap (₹ in Mn) 0.09
Dividend Yield(%) 1.17
Price/Earning (TTM) 19.16
TTM EPS (₹) 49.08
P/E Ratio 19.69
Book Value(₹) 3.60
PAT Margin (%) 10.10
Face Value (₹) 1.00
ROCE(%) 26.06

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 25159.0 108187.0
Expenses N/A N/A
PBT 4972.0 42398.0
Operating profit 0.0 0.0
Net profit 4706.0 34415.0

Shareholding Pattern

Promoters (% Holding)

75.00%

Mutual funds (% Holding)

4.88%

Non-Institution (% Holding)

6.86%

FI/Banks/Insurance (% Holding)

6.14%

Government (% Holding)

0.00%

FII

6.95%

About Zydus Lifesciences Ltd.

Founded 1995
Managing Director Sharvil P Patel
NSE Symbol ZYDUSLIFE

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,40,134.01 1,831.30 1,548.00 - 1,548.00
Divi's Laboratories Ltd. 1,77,883.86 6,681.00 5,636.50 - 5,636.50
Torrent Pharmaceuticals Ltd. 1,47,526.68 4,351.60 3,101.60 - 3,101.60
Apollo Hospitals Enterprise Ltd. 1,12,696.26 7,820.45 6,677.50 - 6,677.50
Lupin Ltd. 1,12,463.67 2,460.50 1,836.80 - 1,836.80
Cipla Ltd. 1,10,088.66 1,361.00 1,165.70 - 1,165.70
Dr. Reddy's Laboratories Ltd. 1,09,072.97 1,307.00 1,138.50 - 1,138.50
Max Healthcare Institute Ltd. 98,793.98 1,015.10 903.00 - 903.00
Mankind Pharma Ltd. 98,063.24 2,375.40 1,909.70 - 1,909.70
Zydus Lifesciences Ltd. 94,596.06 940.10 835.50 - 835.50
no-content No Records Found

Latest News

May
6
2026
EQUITY Posted on May 6th 2026

Zydus Lifesciences informs about press release

Zydus Lifesciences has enclosed a copy of press release dated May 6, 2026, titled ‘USFDA inspection concludes at Zydus' Biologics Injectable plant, Ahmedabad’. The contents of the press release give full details.
The above information is a part of company’s filings submitted to BSE.
Read More
May
5
2026
EQUITY Posted on May 5th 2026

Zydus Lifesciences informs about updates

Zydus Lifesciences has informed that it enclosed Receipt of Demand Order-In-Original from Deputy Commissioner of CGST & Central Excise, Ahmedabad North Commissionerate by Zydus VTEC, a wholly owned subsidiary company.
The above information is a part of company’s filings submitted to BSE.
Read More
Apr
22
2026
EQUITY Posted on Apr 22nd 2026

Zydus Lifesciences informs about newspaper publication

Zydus Lifesciences has informed that it enclosed the Newspaper Publication of Notice for opening of Special Window for transfer and dematerialization of physical securities, published in the Financial Express English and Gujarati Editions, both on April 22, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Apr
10
2026
EQUITY Posted on Apr 10th 2026

Zydus Lifesciences informs about ESG rating

Zydus Lifesciences has informed that ESG Risk Assessments and Insights (‘ESGRAIL’), a SEBI registered ESG Rating Provider has assigned overall ESG rating of 68 (last year 66) to the Company. The report was received by way of an email on April 9, 2026, at 15:30 hours. The Company had not engaged ESGRAIL for the ESG Rating. ESGRAIL has independently prepared the report based on publicly available information. This disclosure is made in compliance with the provisions of regulation 30 of the Listing Regulations read with the SEBI Circular.
The above information is a part of company’s filings submitted to BSE.
Read More
Apr
8
2026
EQUITY Posted on Apr 8th 2026

Zydus Lifesciences informs about press release

Zydus Lifesciences has informed that it enclosed a copy of press release dated April 8, 2026, titled ‘Zydus receives final approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg’.
The above information is a part of company’s filings submitted to BSE. 
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Zydus Lifesciences Ltd. ?

The current share price of Zydus Lifesciences Ltd. is ₹940.30 as of 2026-05-07.

The market capitalisation of Zydus Lifesciences Ltd. is ₹94,596.06 as of 2026-05-07.

The 1-year return of Zydus Lifesciences Ltd. is 0.00% as of 2026-05-07.

The P/E ratio of Zydus Lifesciences Ltd. is 19.69 as of 2026-05-08.

The 52-week high and low of Zydus Lifesciences Ltd. are ₹1,059.05 and ₹835.50, respectively, as of 2026-05-07.

The dividend yield of Zydus Lifesciences Ltd. is 1.1701% as of2026-05-07.

You can buy Zydus Lifesciences Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Zydus Lifesciences Ltd. is Sharvil P Patel.

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

Disclaimer

This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Personal Loan
My Accounts
My Accounts
Explore
Explore